Figma (FIG)
Executive Summary & Action Plan
Verdict
HOLD (Wait out the lockup, then accumulate) — The fundamentals argue value: 46% growth, a sweep-high 139% net dollar retention that accelerated through the disruption headlines, and the first hard proof of consumption monetization. But two forces own the next six weeks: stock compensation running 51% of revenue (the real valuation debate), and ~77.7M locked shares — roughly tripling the tradable float — freeing around August 17. Patience is the position.
Price $21.11 | Market cap $11.2B | Target $26 | Upside +21.7% IWANNAVY Fair Value · price as of 2026-07-11 close · Street consensus $30.56 (reference; n=9 — thin post-IPO coverage, 52.4% dispersion) — our discount to Street is the SBC treatment: full expensing prints $14.7, zero expensing ~$26; the market is pricing exactly half the debate
Abstract
Figma is the highest-beta expression of the prompt-to-design debate, down 85% from its post-IPO high while its operating evidence improved: revenue re-accelerated to +46%, paid customers grew 54%, the $100K+ cohort grew 48%, and NDR reached a two-year-high 139% in the very quarter Claude Design (4/17) and Google Stitch hit the tape. The consumption thesis got its first hard datapoint — 75% of enterprises exceeding AI credit limits purchased more — and the MCP server positions .fig files as the machine-readable context AI coding agents consume, the strongest "AI conforms to Figma" evidence available. Two honest problems price the stock: SBC at 51% of revenue makes owner earnings negative until ~FY29 (the reverse-DCF shows the market expensing only half of it), and the August 17–31 extended-lockup release (~$1.6B of mostly in-profit VC stock against ~$500M daily volume) collides with the 8/13 print. Our $26 fair value is the log-median of a full-SBC DCF ($14.7), 30x forward FCF ($27.4), and growth-adjusted sales ($25.7). Rating: HOLD — do not add before the unlock; the accumulation zone is $16–18 through the window.
Action Plan
The Facebook-2012 precedent says a fully front-run unlock can mark the low — after the fear is priced. Hold core; no adds before ~8/17; accumulate $18 and $16 through the window; trim only into a pre-print squeeze above $26.
- Risk/Reward 0.9:1 at market, ~3.2:1 from $16 | Prob-weighted 12M return +9.9% (Bull 25% × +46.4% + Base 45% × +21.7% + Bear 30% × −38.4%) | Confidence: Low-Medium — one year listed, six weeks of consumption data
Last Four Quarters
Revenue stepped $250M → $333M with the GAAP lines wrecked by design: Q3'25's −415% operating margin was a one-time $975.7M IPO-RSU cumulative catch-up (3.6x that quarter's revenue); the ongoing −41% reflects the $169M/quarter post-IPO SBC run-rate. Non-GAAP OM is +16%, FCF margin 26.6% latest. Gross margin's slide from 91.5% to 79.4% bundles RSU-related COGS with real AI inference cost — the line to watch as credits scale. (The margin chart omits operating margin: the Q3'25 outlier destroys the axis; the table carries it.)
GAP verification (−5.17% on the 7/10 session): idiosyncratic — a failed relief rally rejected at the 100-day moving average (~$22.05) after a +9% initiation-driven week; CRM and ADBE closed green the same day.
Revenue & Profit Mix
No product-level revenue disclosure — the structure that matters is the seat base (eight surfaces) with an emerging AI-credit consumption layer, and the cohort mix: 15,218 customers >$10K (+37%), 1,525 >$100K (+48%). Q1'26 per the 5/14 release.
Business Lines
- Core design canvas (Figma Design + FigJam, large majority of ARR): est. 80–90% of professional UI/UX. Must know — near-monopoly share means growth must come from non-designer seats and pricing; Q1's upside was "seat expansion across entire organizations" — that TAM is still opening.
- Dev Mode + MCP: Must know — the strongest "AI conforms to Figma" evidence: the MCP server makes design systems the structured context Claude Code/Cursor consume — machine-readable infrastructure, not a bypassable drawing.
- AI/generative (Make + Weave + credits): Must know — Figma is running toward the disruption: if prompt-to-design wins, it wants to own the prompt box. Weave GA (timing likely disclosed 8/13) switches on credit consumption; watch gross margin for inference drag.
- New surfaces (Slides, Sites, Buzz, Draw): Must know — widen the funnel feeding 139% NDR; entrenched cheaper competitors (Canva, Adobe Express); treat as free optionality.
IWANNAVY Fair Value
Log-median lands at $26. The spread IS the thesis: the identical operating path is worth ~$26 with SBC forgiven and $14.7 with it fully expensed — the market at $21 is pricing half the SBC debate, not the disruption (bear $5.6 would price that). The lockup is the event that tests whether insiders agree with the half-SBC treatment.
- Thesis breaker (toward SELL): NDR slipping to mid-130s or new-logo growth stalling on 8/13 — funnel interception becoming visible converts the discount into fair pricing ($11–14 zone). (toward BUY): a clean unlock absorption (FB-2012 pattern) plus quantified consumption revenue — the two open questions answered at once.
Catalysts & Risks
References
- Figma Q1'26 results — +46%, NDR 139%, FY26 raised (8-K/press release, 2026-05-14) · Q3'25 10-Q — $975.7M IPO-RSU charge · Q1'26 10-Q — SBC $169.0M
- BofA reinstates Buy $30 — "AI a growth catalyst" (2026-07-07) · Citi bullish initiation $36 (2026-07-01) · Benzinga — rejected at the 100-day MA (2026-07-10)
- Extended Lock-Up 8-K (2025-08-30) — 77.7M shares / 54.1% of Class A, release earlier of 2nd trading day post-Q2-print or 8/31 · VentureBeat — Claude Design launch (2026-04-17) · Motley Fool — why FIG lost 52% in H1 (2026-07-10)
면책사항 · 본 IC 메모는 IWANNAVY LAB의 내부 투자 리서치 자료이며, 공개된 정보와 에이전트 기반 분석을 종합한 교육·연구 목적 문서입니다. 투자 권유·매수/매도 추천이 아니며, 모든 투자 판단과 책임은 투자자 본인에게 있습니다. 가격 데이터는 yfinance + Finviz Elite 교차검증으로 2026-07-12 기준이며, 시장 동향에 따라 실시간 변동할 수 있습니다.
Comments are public. Posting is limited to paid members.
Posting is available on LAB Pro
Sign in, then upgrade to join the discussion.
Loading comments...